Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Covidien Completes Somanetics Acquisition

Covidien, a global provider of healthcare products to medical device industries, has completed the acquisition of Somanetics for an aggregate consideration of approximately $250m, net of cash and short-term investments acquired.

Pursuant to the terms of the merger agreement, Covidien DE Corp., an indirect wholly-owned subsidiary of Covidien, exercised its option to purchase newly issued shares from Somanetics at the tender offer price of $25.00 per share.

Following the purchase, Covidien DE Corp. owned sufficient shares to effect a short-form merger with and into Somanetics, which then became an indirect wholly-owned subsidiary of Covidien. Thereafter, Somanetics common shares ceased to be traded on the NASDAQ Global Market.

Covidien is a global healthcare products company that creates medical solutions for better patient outcomes and delivers value through clinical leadership and excellence.

Covidien manufactures, distributes and services a diverse range of product lines in three segments Medical Devices, Pharmaceuticals and Medical Supplies.